Skip to content

8-KAccepted Sep 4, 4:42 PM ET

Stewards, Inc. Enters Amendment to Loan Agreement; Extends Closing Date

SWRDStewards, Inc.

Accepted (ET)

4:42 PM

Sep 4, 2026

Filed

Sep 4, 2026

Documents

12

Size

175.2 KB

Summary

Stewards, Inc. Enters Amendment to Loan Agreement; Extends Closing Date

Updated

What Happened
Stewards, Inc. announced Amendment No. 4 to its Loan Agreement with Stewards International Funds PCC (on behalf of the Stewards Private Credit Fund), effective as between the parties at 11:59 p.m. ET on August 31, 2026 and executed on September 3, 2026. The amendment extends the facility Closing Date from August 31, 2026 to November 15, 2026, leaves the fixed annual interest rate at 8.00% and keeps the Maturity Date at August 31, 2030 and the $100.0 million aggregate facility limit unchanged. The filing also references related Items 2.03 and 3.02 concerning the creation of a direct financial obligation and unregistered sales of equity securities tied to the loan/warrants.

Key Details

  • Loan facility cap: $100.0 million aggregate principal (no increase).
  • Interest & maturity: fixed 8.00% annual interest; Maturity Date remains August 31, 2030.
  • Warrant terms: Facility Warrant exercise price stays $0.76 per share; coverage for amounts funded on or before Aug 31, 2026 remains 1 warrant per $0.76 funded. For principal funded after Aug 31, 2026 through Nov 15, 2026, coverage is reduced to 1 warrant per $3.00 funded.
  • Issuance timing & restrictions: Company must issue all earned Facility Warrants by Nov 15, 2026; shares issued on exercise will be restricted (not freely tradable unless registered or exempt).
  • Related party: Glen Steward, Board Chairman, is a related party; he disclosed his interest and abstained, and four disinterested directors approved the Amendment.

Why It Matters
The amendment gives Stewards more time (until Nov 15, 2026) to draw on the existing credit facility without changing the overall size, interest rate, or maturity — a near-term liquidity/timing accommodation. The reduced warrant coverage for any extension-period funding (1 warrant per $3.00 vs. 1 per $0.76 previously) limits potential equity dilution from new draws after Aug 31, 2026. Investors should note the related-party approval and that the amendment itself does not automatically advance additional funds; the actual impact depends on how much principal the company elects to borrow and accept during the extended period.

AI-written summary · check the filing